Drug Database
Back to search

Belgium· BE-AMP-SAM552000-00

Rhokiinsa 200 µg/ml

A netarsudil product containing netarsudil mesylate, registered in Belgium by Santen. The same ATC class is registered in 10 of our 19 countries.

ATC S01EX05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRhokiinsa 200 µg/mlATCS01EX05REGISTER NO.BE-AMP-SAM552000-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about netarsudil mesylateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Netarsudil is registered in 10 of 19 countries.

Countries holding a registration under ATC S01EX05 (netarsudil), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search netarsudil products by name

Netarsudil · ATC S01EX05

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Netarsudil Mesylate
Manufacturer
Santen
Country
Belgium (BE)
ATC code
S01EX05
ATC class
Netarsudil
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Netarsudil in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All netarsudil products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Rhokiinsa
  • Liechtenstein · Rhokiinsa
  • Norway · Rhokiinsa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f70b1a83-cb48-47d5-89f4-390600da35e9
GET /v1/drugs/f70b1a83-cb48-47d5-89f4-390600da35e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Rhokiinsa 200 µg/ml",
  "name_fr": "Rhokiinsa 200 µg/ml",
  "name_nl": "Rhokiinsa 200 µg/ml",
  "amp_code": "SAM552000-00",
  "strengths": [
    "200.0000",
    "150.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Netarsudil Mesylate",
    "Netarsudil",
    "Benzalkonium Chloride",
    "Boric Acid",
    "Mannitol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Netarsudil",
  "authorisation_numbers": [
    "EU/1/19/1400/001"
  ]
}
API referenceMCP serverPlans

See everything about netarsudil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console